Profile data is unavailable for this security.
About the company
ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
- Revenue in USD (TTM)8.34m
- Net income in USD-10.92m
- Incorporated2008
- Employees31.00
- LocationReShape Lifesciences Inc1001 CALLE AMANECERSAN CLEMENTE 92673United StatesUSA
- Phone+1 (949) 429-6680
- Fax+1 (302) 636-5454
- Websitehttps://www.reshapelifesciences.com/obalon/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Applied DNA Sciences Inc | 5.52m | -12.50m | 3.97m | 53.00 | -- | -- | -- | 0.7191 | -17.13 | -17.13 | 7.67 | -0.0558 | 0.3893 | 10.38 | 4.64 | 104,110.80 | -87.15 | -88.57 | -111.09 | -121.91 | 33.98 | 44.35 | -223.89 | -113.26 | 1.54 | -- | -- | -- | -26.43 | 27.92 | -18.73 | -- | 33.80 | -- |
Predictive Oncology Inc | 1.96m | -14.78m | 3.97m | 34.00 | -- | 0.9702 | -- | 2.03 | -3.66 | -3.66 | 0.4853 | 0.9977 | 0.1099 | 1.71 | 4.95 | 57,642.65 | -82.89 | -91.80 | -108.54 | -126.29 | 64.18 | 64.64 | -754.19 | -1,419.99 | 1.35 | -- | 0.0093 | -- | 18.24 | 4.75 | 45.67 | -- | 5.44 | -- |
Venus Concept Inc | 73.30m | -37.39m | 4.01m | 304.00 | -- | -- | -- | 0.0548 | -6.69 | -6.69 | 13.12 | -3.54 | 0.7409 | 1.06 | 2.21 | 241,125.00 | -37.61 | -32.71 | -56.83 | -44.01 | 68.37 | 68.16 | -50.77 | -48.50 | 1.35 | -3.44 | 1.40 | -- | -23.26 | 28.31 | 14.76 | -- | -35.08 | -- |
Sharps Technology Inc | 0.00 | -8.71m | 4.04m | 3.00 | -- | 0.5893 | -- | -- | -0.6204 | -0.6204 | 0.00 | 0.4378 | 0.00 | -- | -- | -- | -74.67 | -- | -95.84 | -- | -- | -- | -- | -- | 0.492 | -- | 0.00 | -- | -- | -- | -112.12 | -- | -- | -- |
Therapeutic Solutions International Inc | 97.68k | -2.18m | 4.13m | 3.00 | -- | 2.70 | -- | 42.31 | -0.0006 | -0.0006 | 0.00003 | 0.0003 | 0.0257 | 1.30 | 5.44 | 32,560.00 | -63.47 | -162.32 | -172.17 | -- | 63.36 | 67.79 | -2,468.37 | -2,391.85 | 0.4652 | -6.42 | 0.2868 | -- | -52.13 | 95.35 | 43.11 | -- | -- | -- |
Reflect Scientific Inc | 1.27m | -343.17k | 4.28m | 7.00 | -- | 2.30 | -- | 3.38 | -0.004 | -0.004 | 0.0148 | 0.0217 | 0.5129 | 0.6184 | 5.72 | 181,111.40 | -13.88 | 11.10 | -16.43 | 13.21 | 56.06 | 62.48 | -27.07 | 10.00 | 2.21 | -- | 0.00 | -- | -47.09 | -6.99 | -613.46 | -- | -- | -- |
Hawkeye Systems Inc | 0.00 | -804.18k | 4.33m | 44.00 | -- | -- | -- | -- | -0.1186 | -0.1186 | 0.00 | -0.29 | 0.00 | -- | -- | -- | -66.07 | -330.11 | -- | -- | -- | -- | -- | -218.49 | -- | -2.78 | 10.45 | -- | -- | -- | 4.85 | -- | -- | -- |
Arch Therapeutics Inc | 130.55k | -8.43m | 4.40m | 8.00 | -- | -- | -- | 33.70 | -3.68 | -3.68 | 0.0425 | -2.45 | 0.0833 | 0.0637 | -- | 16,318.75 | -538.25 | -188.28 | -- | -804.63 | 33.37 | -- | -6,458.14 | -26,945.92 | 0.0164 | -1.27 | -- | -- | 383.83 | -- | -32.35 | -- | -21.76 | -- |
Dror Ortho-Design Inc | 0.00 | -4.83m | 4.46m | 4.00 | -- | 1.87 | -- | -- | -0.0115 | -0.0115 | 0.00 | 0.0048 | 0.00 | -- | -- | -- | -357.10 | -140.50 | -595.21 | -- | -- | -- | -- | -118,188.00 | -- | -- | 0.00 | -- | -- | -- | -1,896.02 | -- | -- | -- |
ADM Tronics Unlimited Inc | 2.85m | -716.86k | 4.50m | 7.00 | -- | 4.08 | -- | 1.58 | -0.0106 | -0.0106 | 0.0421 | 0.0163 | 0.9772 | 3.85 | 4.25 | -- | -24.62 | -11.45 | -38.81 | -15.77 | 38.45 | 43.73 | -25.19 | -15.28 | 1.24 | -- | 0.2902 | -- | 14.66 | -0.4159 | 93.04 | -- | -- | -- |
Nu-Med Plus Inc | 0.00 | -119.16k | 4.69m | 2.00 | -- | -- | -- | -- | -0.0014 | -0.0014 | 0.00 | -0.002 | 0.00 | -- | -- | 0.00 | -350.01 | -447.69 | -- | -- | -- | -- | -- | -- | -- | -22.74 | -- | -- | -- | -- | 3.56 | -- | -- | -- |
ReShape Lifesciences Inc | 8.34m | -10.92m | 4.84m | 31.00 | -- | 1.07 | -- | 0.5803 | -2.30 | -2.30 | 0.7319 | 0.1933 | 0.6781 | 0.8178 | 4.52 | 268,871.00 | -88.83 | -136.06 | -162.20 | -194.32 | 65.85 | 56.30 | -130.99 | -408.36 | 1.26 | -- | 0.00 | -- | -22.79 | -0.9474 | 75.36 | -- | -49.29 | -- |
Pressure Biosciences Inc | 1.98m | -35.20m | 4.86m | 15.00 | -- | -- | -- | 2.46 | -1.65 | -1.65 | 0.0885 | -0.9261 | 1.29 | 2.38 | 8.86 | 131,850.70 | -1,916.46 | -872.30 | -- | -- | 40.43 | 32.33 | -1,482.20 | -1,066.48 | 0.0136 | -0.595 | -- | -- | 14.37 | -4.25 | -97.72 | -- | -- | -- |
Encision Inc | 6.87m | -448.00k | 4.99m | 31.00 | -- | 2.25 | -- | 0.7263 | -0.0381 | -0.0381 | 0.5835 | 0.1863 | 1.64 | 1.96 | 7.84 | 221,520.00 | -10.69 | -1.07 | -14.05 | -1.46 | 50.54 | 52.27 | -6.52 | -0.613 | 1.08 | -6.22 | 0.1123 | -- | -4.17 | -3.44 | -393.90 | -- | 12.89 | -- |
Sonendo Inc | 40.19m | -57.74m | 5.38m | 216.00 | -- | 0.2194 | -- | 0.1339 | -0.6125 | -0.5552 | 0.426 | 0.3482 | 0.4448 | 2.07 | 7.58 | 186,055.60 | -63.91 | -- | -78.82 | -- | 27.64 | -- | -143.67 | -- | 2.14 | -10.83 | 0.4695 | -- | 5.30 | -- | -6.78 | -- | -- | -- |
Bionoid Pharma Inc | 0.00 | 1.35m | 5.40m | 13.00 | 0.0882 | -- | 3.99 | -- | 1.13 | 1.13 | 0.00 | -0.1744 | -- | -- | -- | -- | -- | -506.64 | -- | -- | -- | -- | -- | -- | -- | 327.24 | -- | -- | -- | -- | -31.55 | -- | 26.01 | -- |
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 31 Mar 2024 | 49.87k | 0.21% |
Tower Research Capital LLCas of 31 Mar 2024 | 49.57k | 0.21% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 34.06k | 0.15% |
Millennium Management LLCas of 31 Mar 2024 | 29.79k | 0.13% |
Gesalcal� SA SGIICas of 31 Dec 2023 | 26.01k | 0.11% |
Goldman Sachs & Co. LLC (Private Banking)as of 31 Mar 2024 | 23.04k | 0.10% |
Jane Street Capital LLCas of 31 Mar 2024 | 22.93k | 0.10% |
Geode Capital Management LLCas of 31 Mar 2024 | 18.35k | 0.08% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 13.02k | 0.06% |
Two Sigma Securities LLCas of 31 Mar 2024 | 12.82k | 0.06% |